Iridex (IRIX) EBITDA (2010 - 2026)

Iridex's EBITDA history runs 17 years deep, the most recent figure standing at -$324000.0 for Q2 2026.

• On a quarterly basis, EBITDA fell 58.05% year-over-year to -$324000.0 in Q2 2026; TTM through Apr 2026 was -$2.7 million, a 48.42% increase from a year earlier, with the FY2026 full-year figure at -$2.6 million, up 69.03% from the prior year.
• EBITDA fell to -$324000.0 in Q2 2026 per IRIX's latest filing, from -$15000.0 in the prior quarter.
• Across five years, EBITDA topped out at -$15000.0 in Q1 2026 and bottomed at -$3.3 million in Q1 2024.
• The 5-year median for EBITDA is -$1.7 million (2022), against an average of -$1.7 million.
• Across the five-year window, EBITDA sank 118.51% in 2023 and surged 97.01% in 2026, its largest moves.
• Year by year, EBITDA stood at -$1.4 million in 2022, then sank by 118.51% to -$3.1 million in 2023, then jumped by 83.71% to -$502000.0 in 2024, then plunged by 181.08% to -$1.4 million in 2025, then soared by 77.04% to -$324000.0 in 2026.
• Per Business Quant, the three latest IRIX EBITDA figures stand at -$324000.0 (Q2 2026), -$15000.0 (Q1 2026), and -$1.4 million (Q3 2025).